Bruker Corporation to Present at Jefferies 2022 Global Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) will present at the Jefferies 2022 Global Healthcare Conference in New York on June 9, 2022, at 3:00 pm EDT. Frank Laukien, CEO, and Justin Ward, Sr. Director of Investor Relations, will represent the company. A live audio webcast will be available on the Investor Relations section of Bruker's website, with a replay accessible for 30 days post-event. Bruker is dedicated to advancing scientific discovery and enhancing human life through its innovative analytical solutions and high-performance scientific instruments.
- None.
- None.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.
About
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220525005847/en/
Sr. Director, Investor Relations & Corporate Development
T: +1 (978) 663–3660, ext. 1479
E: Investor.Relations@bruker.com
Source:
FAQ
When will Bruker Corporation present at the Jefferies 2022 Global Healthcare Conference?
Who will present for Bruker Corporation at the Jefferies Conference?
Where can I watch the Bruker Corporation presentation live?
How long will the replay of Bruker Corporation's presentation be available?
What is the stock symbol for Bruker Corporation?
